RSS

malaria

To mark World Malaria Day, the founder of specialist smartphone diagnostics company Novarum DX and BBI Group head of mobile, Dr Neil Polwart, has spoken out to highlight the importance of new diagnostic technologies in tackling the spread of malaria more

Opinion

In this online exclusive, anti-malarial specialist, TravelPharm, and digital agency, Fifteen, reveal their research findings, which show that more work is needed in communicating malarial risks to travellers… more

Opinion

International nonprofit organization, PATH, and UK-based test developer, Mologic, have entered into an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax or relapsing malaria. more

Technology

Global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, Cardiabase — a Banook Group company, is supporting the World Health Organization (WHO) in the fight against malaria. more

News

The World Health Organisation Regional Office for Africa (WHO/AFRO) has announced that Ghana, Kenya and Malawi will take part in the malaria vaccine pilot implementation programme starting in 2018. more

News

Catalent Pharma Solutions, provider of advanced delivery technologies and development solutions for drugs has announced a collaboration with Path, a nonprofit organisation to advance a project funded by its Malaria Vaccine Initiative. more

News

Medicines for Malaria Venture (MMV) and Cresset Discovery Services will use computer-aided drug discovery in their collaboration effort to identify back-up compounds for a recently discovered molecule in MMV’s portfolio more

News

UK startup MediSieve is working on a magnetic blood filtering device that captures and removes malaria infected red cells more

News

GlaxoSmithKline (GSK) has partnered with the Francis Crick Institute on an open science collaboration, the aim of which is to forge new scientific discoveries. more

News

WHO prequalification has been awarded to Novartis' antimalarial medicine Coartem 80/480 mg, making it the first high strength artemisinin-based combination therapy antimalarial treatment available for public sector procurement. more

News

Scientists have identified a key protein that if targeted prevents the malaria parasite's survival, a discovery that could pave the way to a cure for the disease. more

News